Abstract

BackgroundThe effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available.MethodsWe reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models.ResultsAcross all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55–64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09–2.24), followed by effects on both stroke subtypes (1.66; 1.39–1.98 for hemorrhagic stroke and 1.63; 1.57–1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29–1.61) for IHD and 1.20 (1.15–1.25) for ischemic stroke. The RRs for 5 kg/m2 higher BMI for ages 55–64 ranged from 2.32 (2.04–2.63) for diabetes, to 1.44 (1.40–1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08–1.29) for IHD and 1.14 (1.01–1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs.ConclusionOur results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.

Highlights

  • Roughly 17 million deaths are caused by cardiovascular disease (CVD) and diabetes each year [1]

  • Effect estimates in prior global comparative risk assessment (CRA) analyses of metabolic risk factors including systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) were based on the Asia Pacific Cohort Studies Collaboration (APCSC) and selected other cohort pooling studies [3,4,5,6,7,8,9,10,11,12,13]

  • For SBP, TC, and FPG, we focused on the usual distribution, i.e., the distribution that has been corrected for temporal changes in measurement over time

Read more

Summary

Introduction

Roughly 17 million deaths are caused by cardiovascular disease (CVD) and diabetes each year [1]. Effect estimates in prior global comparative risk assessment (CRA) analyses of metabolic risk factors including systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) were based on the Asia Pacific Cohort Studies Collaboration (APCSC) and selected other cohort pooling studies [3,4,5,6,7,8,9,10,11,12,13]. The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call